Novo Nordisk conducts a two-for-one stock split
13 Septiembre 2023 - 12:30AM
Novo Nordisk conducts a two-for-one stock split
Bagsværd, Denmark, 13 September 2023 – As
communicated on 10 August 2023 in connection with the release of
Novo Nordisk's financial results for the first six months of 2023,
Novo Nordisk's Board of Directors has approved a split of the
trading units of the Novo Nordisk B shares listed on Nasdaq
Copenhagen and of the American Depositary Receipts (ADRs) listed on
New York Stock Exchange (NYSE) in a two-for-one ratio.
Novo Nordisk’s B shares have been listed on Nasdaq Copenhagen in
trading units of DKK 0.20 and its American Depositary Receipts
(ADRs) that equal B-shares of DKK 0.20 have been listed on New York
Stock Exchange (NYSE).
Consequently, the trading unit of the Novo Nordisk B shares
listed on Nasdaq Copenhagen has been changed from DKK 0.20 to DKK
0.10 as of 13 September 2023. The ADRs will similarly be split as
of 20 September 2023 to maintain the one-to-one relationship
between the B-share and the ADR.
Novo Nordisk is a leading global healthcare company, founded in
1923 and headquartered in Denmark. Our purpose is to drive change
to defeat serious chronic diseases, built upon our heritage in
diabetes. We do so by pioneering scientific breakthroughs,
expanding access to our medicines, and working to prevent and
ultimately cure disease. Novo Nordisk employs about 59,000 people
in 80 countries and markets its products in around 170 countries.
For more information, visit novonordisk.com, Facebook, Instagram,
X, LinkedIn and YouTube.Contacts
for further information
|
Media: |
|
|
Ambre
James-Brown +45 3079
9289abmo@novonordisk.com |
Elizabeth
DeLuca (US)+1 609 580
9868edel@novonordisk.com |
|
Investors: |
|
| Daniel
Muusmann Bohsen+45 3075 2175 dabo@novonordisk.com |
Jacob
Martin Wiborg Rode+45 3075 5956jrde@novonordisk.com |
| David
Heiberg Landsted +45 3077 6915 dhel@novonordisk.com |
Mark
Joseph Root (US) +1 848 213 3219mjhr@novonordisk.com |
|
Sina Meyer +45 3075 6656
azey@novonordisk.com |
Frederik
Taylor Pitter +45 3075 8259 fptr@novonordisk.com |
Novo Nordisk (TG:NOVC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Novo Nordisk (TG:NOVC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
